Chargement en cours...
Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial
OBJECTIVE: Many patients receiving dual antiplatelet therapy still had recurrent strokes. We aimed to identify factors associated with recurrent stroke at 90 days in patients receiving dual antiplatelet therapy in Clopidogrel in High-risk patients with Acute Non-disabling Cerebrovascular Events tria...
Enregistré dans:
| Publié dans: | Stroke Vasc Neurol |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5829906/ https://ncbi.nlm.nih.gov/pubmed/29507777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/svn-2017-000088 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|